title: [Unclear hepatopathy in a patient with atrial fibrillation].
abstract: Although liver damage is a relatively rare adverse effect of oral anticoagulation with phenprocoumon, acute liver failure can be a serious treatment-associated complication. In this contribution, a patient with drug-induced liver failure during oral anticoagulation with phenprocoumon is presented. This case illustrates the need for close laboratory monitoring and suggests that phenrocoumon-induced liver damage should be considered along with other common complications of this treatment.
authors: Medizinische Klinik I, St. Josef Hospital, Klinikum der Ruhr-Universität Bochum, Bochum, Deutschland. ch.pennartz@web.de
authors: C
authors: C
authors: Pennartz
authors: H
authors: H
authors: Schrader
authors: P R
authors: PR
authors: Ritter
authors: A
authors: A
authors: Tannapfel
authors: W E
authors: WE
authors: Schmidt
authors: J J
authors: JJ
authors: Meier
mesh_terms: D000284:Administration, Oral; D000368:Aged; D000925:Anticoagulants / Q000008:administration & dosage / Q000009:adverse effects; D001281:Atrial Fibrillation / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D017093:Liver Failure / Q000139:chemically induced* / Q000517:prevention & control*; D008297:Male; D010644:Phenprocoumon / Q000008:administration & dosage* / Q000009:adverse effects*
chemical_list: D000925:Anticoagulants; D010644:Phenprocoumon